Solved Case Analysis: ZYRTEC: Responding to Allegra by Marian Chapman Moore, Karin Bergqvist, Angela Li

Get the Best Analysis to this Case Study written by MBA/CFA writers.

**Order Now by just sending an email at assignment@writerkingdom.com . Send us case study file and questions which you want to get covered in case solution. Click Here to see how it works

Compare

Description

In April 2010, the ZYRTEC brand manager at Johnson & Johnson’s McNeil Consumer Healthcare, learned that Sanofi’s Allegra, the leading brand in the prescription antihistamine category, was anticipated to secure over-the-counter (OTC) approval by spring 2011. With the recent successful launch of ZYRTEC Liqui-Gels, ZYRTEC was poised to overtake Merck’s Claritin, the leader in the OTC antihistamine category. The case asks students to recommend how a strong brand might respond to a new market entrant that threatens to disrupt the category. The case is used in Darden’s Consumer Brands elective course and would fit in courses covering consumer marketing, brand marketing, or brand strategy as well as a first-year marketing management course. Although written for an MBA audience, the content and decision points are easily accessible to advanced undergraduate marketing students and an Executive Education audience.

Publishing Authority:

Darden Business Publishing – University of Virginia

Reviews

There are no reviews yet.

Be the first to review “Solved Case Analysis: ZYRTEC: Responding to Allegra by Marian Chapman Moore, Karin Bergqvist, Angela Li”

Your email address will not be published. Required fields are marked *